Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions

Journal of Microencapsulation

Volumn 27, Issue 2, 2010, Pages 162-170

  Learoyd, Tristan P ^a   Burrows, Jane L ^b   French, Eddie ^b   Seville, Peter C ^c  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

Chitosan; Double emulsion; PLGA; Respirable; Spray drying

Indexed keywords

CHITOSAN; LEUCINE; POLYGLACTIN; SALBUTAMOL SULFATE;

AEROSOL; APPARATUS; AQUEOUS SOLUTION; ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; MICROEMULSION; MOLECULAR WEIGHT; PARTICLE SIZE; POWDER; SPRAY DRYING; SUSTAINED DRUG RELEASE;

EID: 77149147746     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040903052044     Document Type: Article

References (27)

1. Anal AK, Stevens WF, Remunan-Lopez C. 2006. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm 312:166-173.
2. Ankerst J. 2005. Combination inhalers containing inhaled corticosteroids and long-acting beta(2)-agonists: Improved clinical efficacy and dosing options in patients with asthma. J Asthma 42:715-724.
3. Black SD, Mould DR. 1991. Amino acid scale: Hydrophobicity of physiological L-alpha amino acids. Anal Biochem 193:72-82.
4. Blanco MD, Sastre RL, Teijon C, Olmo R, Teijon JM. 2006. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 326:139-147.
5. Bosquillon C, Lombry C, Preat V, Vanbever R. 2001a. Comparison of particle sizing techniques in the case of inhalation dry powders. J Pharm Sci 90:2032-2041.
6. Bosquillon C, Lombry C, Preat V, Vanbever R. 2001b. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Contr Rel 70:329-339.
7. Bosquillon C, Prat W, Vanbever R. 2004. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Contr Rel 96:233-244.
8. Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Preat V, et al. 2004. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Contr Rel 99:357-367.
9. Cilurzo F, Selmin F, Minghetti P, Rimoldi I, Damartin F, Montanari L. 2005. Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam. Eur J Pharm Sci 24:355-361.
10. De Villiers MM. 2005. Paper flow and compressibility. In: Ghosh TK, Jasti BR, editors. Theory and practice of contemporary pharmaceuticals. Boca Raton: CRC Press. pp 298-299.
11. Dyer MJ, Halpin DMG, Stein K. 2006. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: A systematic review. BMC Fam Pract 7:34.
12. Learoyd TP, Seville PC. 2007. Respirable powders. Worldwide Patent, 31.05.2007.
13. Learoyd TP, Burrows JL, French E, Seville PC. 2008a. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 68:224-234.
14. Learoyd TP, Burrows JL, French E, Seville PC. 2008b. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Tech 187:231-238.
15. Li HY, Birchall J. 2006. Chitosan-modified dry powder formulations for pulmonary gene delivery. Pharm Res 23:941-950.
16. Li HY, Seville PC, Williamson IJ, Birchall JC. 2005. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J Gene Med 7:343-353.
17. Lotvall J. 2002. The long and short of beta(2)-agonists. Pulmon Pharmacol Therapeut 15:497-501.
18. Moffat AC, Osselton DM, Widdop B, Laurent GY. 2004. Clarke's analysis of drugs and poisons. London: Pharmaceutical Press.
19. Reid ML, Brown MB, Moss GP, Jones SA. 2008. An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes. J Pharm Pharmacol 60:1139-1147.
20. Schnieders J, Gbureck U, Thull R, Kissel T. 2006. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27:4239-4249.
21. Seville PC, Learoyd TP, Li HY, Williamson IJ, Birchall JC. 2007. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Tech 178:40-50.
22. Seville PC, Li HY, Learoyd TP. 2007. Spray-dried powders for pulmonary drug delivery. Crit Rev Ther Drug Carrier Syst 24:307-360.
23. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. 2002. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev Ind Pharm 28:1147-1153.
24. Siepmann J, Peppas N. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157.
25. Stempel DA, Stoloff SW, Rosenzweig JRC, Stanford RH, Ryskina KL, Legorreta AP. 2005. Adherence to asthma controller medication regimens. Respir Med 99:1263-1267.
26. Taki M, Zeng XM, Oliver M, Marriott C, Martin GP. 2006. A comparison of the in-vitro deposition profiles of drugs from a combination dry powder inhaler (DIPI) using the Next Generation Impactor (NGI). J Pharm Pharmacol 58:A65.
27. Vehring R. 2008. Pharmaceutical particle engineering via spray drying. Pharm Res 25:999-1022.